Skip to main content
. 2014 Jul 24;8(4):1638–1644. doi: 10.3892/ol.2014.2379

Figure 1.

Figure 1

Tumor growth was observed after tumor segments were inoculated into the SCID/NOD mice, which were injected intraperitoneally human PBMCs or not. (A) The tumor growth curve by palpation, (B) tumors at the fourth week after inoculation, (C) the tumor area by fluorescence imaging and (D) tumor fluorescence imaging after inoculation. *P<0.05, vs. the AM1010+PBMC group. SCID/NOD, non-obese diabetic/severe combined immunodeficient; PBMCs, peripheral blood mononuclear cells.